Baxter International Inc. BAX
26.34 USD -0.08 (-0.30%)
At closeNov 11, 2026, 6:14 PM EST
26.20 -0.14 -0.53%
After hours · Nov 11, 6:14 PM ET
25.98 Day range 26.50
15.73 52-week range 30.00
- YTD
- +37.83%
- 1 year
- +44.33%
News
benzinga.com Barclays Maintains Underweight on Baxter International, Raises Price Target to $23 Barclays analyst Christopher Pasquale maintains Baxter International (NYSE:BAX) with a Underweight and raises the price target from $20 to $23.
defenseworld.net International Assets Investment Management LLC Acquires 72,405 Shares of Baxter International Inc. $BAX International Assets Investment Management LLC increased its holdings in Baxter International Inc. (NYSE: BAX) by 93.3% in the undefined quarter, according to the company in its most recent filing…
benzinga.com JP Morgan Maintains Neutral on Baxter International, Lowers Price Target to $25 JP Morgan analyst Robbie Marcus maintains Baxter International (NYSE:BAX) with a Neutral and lowers the price target from $26 to $25.
benzinga.com Wells Fargo Maintains Equal-Weight on Baxter International, Raises Price Target to $25 Wells Fargo analyst Larry Biegelsen maintains Baxter International (NYSE:BAX) with a Equal-Weight and raises the price target from $23 to $25.
marketbeat.com What Baxter International (BAX) Said on Its Q3 Earnings Call Baxter International NYSE: BAX raised its full-year 2026 outlook after reporting third-quarter sales and adjusted earnings that exceeded its expectations, citing broad-based growth across its…
zacks.com Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook Raised BAX beats Q3 earnings and revenue estimates, driven by broad-based segment growth, and raises its 2026 outlook despite continued margin pressure.
seekingalpha.com Baxter International Inc. (BAX) Q3 2026 Earnings Call Transcript Baxter International Inc. (BAX) Q3 2026 Earnings Call Transcript
benzinga.com Why Is Baxter Stock Trading Lower on Thursday? Baxter International Inc. (NYSE:BAX) on Thursday reported better-than-expected third-quarter financial results and raised its fiscal 2026 guidance.
benzinga.com Why Is Baxter Stock Trading Lower on Thursday? Baxter tops Q3 consensus with 58 cents EPS and $2.976 billion in sales, lifting fiscal 2026 profit and revenue guidance above Wall Street forecasts.
zacks.com Compared to Estimates, Baxter (BAX) Q3 Earnings: A Look at Key Metrics The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
benzinga.com Baxter Intl Q3 2026 Earnings Call Transcript Baxter Intl (NYSE:BAX) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Baxter International (BAX) Q3 Earnings and Revenues Surpass Estimates Baxter International (BAX) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.69 per share a year ago.- benzinga.com Baxter International Raises FY2026 Adj EPS Guidance from $1.95-$2.15 to $2.05-$2.15 vs $2.05 Est; Raises FY2026 Sales Guidance from $11.581B-$11.694B to $11.694B-$11.806B vs $11.619B Est Baxter International (NYSE:BAX) raises FY2026 Adj EPS guidance from $1.95-$2.15 to $2.05-$2.15 vs $2.05 analyst estimate. Raises FY2026 sales outlook from $11.581 billion-$11.694 billion to $11.694…
businesswire.com Baxter Reports Third-Quarter 2026 Results DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2026. “We delivered a strong third quarter, with…
zacks.com Will Baxter's Q3 Earnings Show Progress Despite Cost Pressures? Baxter International Inc. BAX is scheduled to release third-quarter 2026 results on Oct. 29, before the opening bell. In the last reported quarter, the company's earnings beat the Zacks Consensus…
defenseworld.net 20,728 Shares of Baxter International Inc. $BAX Acquired by Cohen Klingenstein LLC Cohen Klingenstein LLC acquired a new position in shares of Baxter International Inc. (NYSE: BAX) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange…
seekingalpha.com Baxter International: The Vantive Transition Complicates Margin Recovery Baxter International is rated Hold, with a $25 target price and limited 2.6% upside, reflecting muted near-term margin recovery. Revenue growth is supported by Advanced Surgery and compounding, but…
defenseworld.net Financial Contrast: Baxter International (NYSE:BAX) and Omnicell (NASDAQ:OMCL) Omnicell (NASDAQ: OMCL - Get Free Report) and Baxter International (NYSE: BAX - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses…
businesswire.com Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2026 financial results on Thursday, October…
zacks.com Are Investors Undervaluing Baxter International (BAX) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
zacks.com Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year? Here is how Baxter International (BAX) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
businesswire.com Baxter Releases Inaugural Connected Hospital Report DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the release of its 2026 Connected Hospital Report, offering new insights into how…
defenseworld.net Baxter International Inc. (NYSE:BAX) Stock Now Rated “Hold” by Wall Street Analysts Baxter International Inc. (NYSE: BAX - Get Free Report) has earned a consensus recommendation of "Hold" from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports.…
zacks.com Why Investors Need to Take Advantage of These 2 Medical Stocks Now The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
zacks.com Here's Why You Should Retain Baxter Stock in Your Portfolio for Now BAX's portfolio reset and growth in connected care and advanced surgery support prospects, but margins, Novum IQ and China pricing remain risks.
benzinga.com Top 3 Health Care Stocks That May Rocket Higher In September CVS, Steris and Baxter are oversold healthcare stocks with RSI readings near or below 30, potentially offering undervalued buying opportunities.
defenseworld.net Bank of America Corp DE Makes New Investment in Baxter International Inc. $BAX Bank of America Corp DE acquired a new position in Baxter International Inc. (NYSE: BAX) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The…
benzinga.com TD Cowen Maintains Hold on Baxter International, Raises Price Target to $29 TD Cowen analyst Joshua Jennings maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $24 to $29.- benzinga.com Wells Fargo Maintains Equal-Weight on Baxter International, Raises Price Target to $23 Wells Fargo analyst Larry Biegelsen maintains Baxter International (NYSE:BAX) with a Equal-Weight and raises the price target from $19 to $23.
benzinga.com Stifel Maintains Hold on Baxter International, Raises Price Target to $28 Stifel analyst Rick Wise maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $24 to $28.- benzinga.com Citigroup Upgrades Baxter International to Neutral, Raises Price Target to $28 Citigroup analyst Joanne Wuensch upgrades Baxter International (NYSE:BAX) from Sell to Neutral and raises the price target from $17 to $28.
benzinga.com Baxter Jumps After Q2 Beat, Boosted 2026 Guidance Reflects Turnaround Progress Baxter stock climbs after second-quarter earnings and revenue topped estimates as the company raised fiscal 2026 sales and profit guidance.- benzinga.com Baxter International Raises FY2026 Adj EPS Guidance from $1.85-$2.05 to $1.95-$2.15 vs $1.91 Est; Raises FY2026 Sales Guidance from $11.244B-$11.356B to $11.581B-$11.694B vs $11.357B Est Baxter International (NYSE:BAX) raises FY2026 Adj EPS guidance from $1.85-$2.05 to $1.95-$2.15 vs $1.91 analyst estimate. Raises FY2026 sales outlook from $11.244 billion-$11.356 billion to $11.581…
benzinga.com Baxter Intl Q2 Adj. EPS $0.54 Beats $0.37 Estimate, Sales $2.960B Beat $2.795B Estimate Baxter Intl (NYSE:BAX) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.37 by 45.95 percent. This is a 8.47 percent decrease over earnings of $0.59 per…- benzinga.com UBS Maintains Neutral on Baxter International, Raises Price Target to $25 UBS analyst Patrick Wood maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $25.
benzinga.com Stifel Maintains Hold on Baxter International, Raises Price Target to $24 Stifel analyst Rick Wise maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $19 to $24.
benzinga.com TD Cowen Maintains Hold on Baxter International, Raises Price Target to $24 TD Cowen analyst Joshua Jennings maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $20 to $24.- benzinga.com Goldman Sachs Maintains Neutral on Baxter International, Raises Price Target to $21 Goldman Sachs analyst David Roman maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $21.
- benzinga.com Evercore ISI Group Maintains Outperform on Baxter International, Raises Price Target to $24 Evercore ISI Group analyst Vijay Kumar maintains Baxter International (NYSE:BAX) with a Outperform and raises the price target from $22 to $24.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com FDA Issues Early Alert Regarding Pressure Breathing Device Issue from Baxter https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-positive-pressure-breathing-device-issue-baxter
- benzinga.com Citigroup Downgrades Baxter International to Sell, Lowers Price Target to $17 Citigroup analyst Joanne Wuensch downgrades Baxter International (NYSE:BAX) from Neutral to Sell and lowers the price target from $19 to $17.
- benzinga.com Barclays Maintains Overweight on Baxter International, Raises Price Target to $27 Barclays analyst Matt Miksic maintains Baxter International (NYSE:BAX) with a Overweight and raises the price target from $25 to $27.
benzinga.com Baxter Profit Plunges 35% As Tariffs, Costs Bite Baxter tops earnings, but profit plunges 35% as tariffs and manufacturing costs rise; outlook for 2026 remains intact.- benzinga.com Baxter International Affirms FY2026 Adj EPS Guidance of $1.85-$2.05 vs $1.91 Est; Affirms FY2026 Sales Guidance of $11.244B-$11.356B vs $11.351B Est Baxter International (NYSE:BAX) affirms FY2026 Adj EPS guidance from $1.85-$2.05 to $1.85-$2.05 vs $1.91 analyst estimate. Affirms FY2026 sales outlook from $11.244 billion-$11.356 billion to $11.244…
- benzinga.com Baxter International Affirms FY2026 Adj EPS Guidance of $1.85-$2.05 vs $1.91 Est Baxter International (NYSE:BAX) affirms FY2026 Adj EPS guidance from $1.85-$2.05 to $1.85-$2.05 vs $1.91 analyst estimate..
- benzinga.com Baxter Intl Q1 Adj. EPS $0.37 Beats $0.31 Estimate, Sales $2.701B Beat $2.616B Estimate Baxter Intl (NYSE:BAX) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.31 by 19.35 percent. This is a 40.32 percent decrease over earnings of $0.62 per…
benzinga.com Earnings Scheduled For April 30, 2026 
benzinga.com Alpha Buying: Following Conviction, Not the Crowd - benzinga.com Evercore ISI Group Maintains Outperform on Baxter International, Lowers Price Target to $22 Evercore ISI Group analyst Vijay Kumar maintains Baxter International (NYSE:BAX) with a Outperform and lowers the price target from $23 to $22.